Assessment of myocardial perfusion using cardiac positron emission tomography;Untersuchung der myokardperfusion mit der positronen-emissions-tomographie

Zeitschrift fur Kardiologie

Volumn 90, Issue 11, 2001, Pages 835-847

  Vom Dahl, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Heart; Positron emission tomography

Indexed keywords

CARDIOVASCULAR AGENT; FLUORODEOXYGLUCOSE F 18; OXYGEN 15; RUBIDIUM 82;

ARTICLE; COMPUTER PROGRAM; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; CYCLOTRON; DIAGNOSTIC ACCURACY; DRUG HALF LIFE; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HUMAN; POSITRON EMISSION TOMOGRAPHY; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY CIRCULATION; CORONARY DISEASE; EXERCISE TEST; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035197360     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920170082     Document Type: Article

References (94)

1. Guidelines for clinical use of cardiac radionuclide imaging
2. Non-invasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography
3. Der einfluss von CSE-hemmern aud endotheldysfunktion und koronarreserve
4. Verbesserung der koronaren vasodilatation duch medikamentöse lipidsenkung bei patienten im frühstadium der koronaren atherosklerose mit eingeschränkter koronarreserve und mäßiggradiger LDL-hypercholesterinämie
5. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis
6. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography: Determination of extent of altered vasuclar reactivity
7. Radionuclide perfusion imaging techniques for evaluation of patients with known or suspected coronary artery disease
8. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease
9. Non-invasive quantitation of myocardial blood flow in human subjects with oxygen-15 labeled water and positron emission tomography
10. Direct comparison of N-13 ammonia and O-15 water estimates of perfusion with quantification of regional myocardial blood flow by microspheres
11. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography
12. The impact of myocardial blood flow quantitation with PET on the understanding of cardiac diseases
13. Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery
14. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity
15. L-Arginine normalizes coronary vasomotion in long-term smokers
16. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men
17. Quantification of myocardial blood flow using 13N-ammonia and PET: Comparison of tracer models
18. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve
19. Influence of age and hemodynamics on myocardial blood flow and flow reserve
20. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction
21. Effect of acute and long-term smoking on myocardial blood flow and flow reserve
22. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography
23. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography
24. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients
25. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging
26. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans
27. Relationship between stenosis severity, hyperemic blood flow, flow reserve, and coronary resistance in CAD patients
28. Myocardial viability in asynergic regions subtended by occluded coronary arteries: Relation to the status of collateral flow in patients with chronic coronary artery disease
29. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries
30. Nitrogen-13-ammonia and oxygen-15-water estimates of absolute myocardial perfusion in left ventricular ischemic dysfunction
31. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction
32. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease
33. Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man
34. Clinical cardiac PET using generator-produced Rb-82: A review
35. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium
36. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification
37. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET
38. Delineation of myocardial viability with PET
39. The time course of restoration of nutritive perfusion, myocardial oxygen consumption, and regional function after coronary thrombolysis
40. Measurement of absolute myocardial blood flow with O-15 water and dynamic positron emission tomography. Strategy for quantification in relation to the partial-volume effect
41. Myocardial tissue fraction: Correction for partial volume effects and measure of tissue viability
42. PET as a cardiovascular and metabolic research tool
43. Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography
44. Dobutamine positron emission tomography: Absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease
45. Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation
46. Early impairment of coronary flow reserve in young men with borderline hypertension
47. Pathophysiology of chronic left ventricular dysfunction: New insights from the measurement of absolute myocardial blood flow and glucose utilization
48. Myocardial perfusion imaging with positron emission tomography and single photon emission tomography: Frequency and causes of disparate results
49. Prognostic implications of Rb-82 positron emission tomography: Four year follow-up of 685 patients
50. Improvement of coronary vasodilatation capacity through single LDL apheresis
51. Assessment of coronary reserve in man: Comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique
52. Automated region definition for cardiac nitrogen-13-ammonia PET imaging
53. Validation of nitrogen-13-ammonia tracer kinetic model for quantitation of myocardial blood flow using PET
54. Recovery of myocardial perfusion in acute myocardial infarction after successful balloon angioplasty and stent placement in the infarct-related coronary artery
55. Noninvasive quantification of myocardial blood flow in humans: A direct comparison of the N-13 ammonia and the O-15 water techniques
56. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease
57. Coronary flow reserve in young men with familial combined hyperlipidemia
58. Coronary flow reserve is reduced in young men with IDDM
59. Coronary flow reserve is impaired in young men with familial hypercholesterolemia
60. Influence of cardiovascular risk status on coronary flow reserve in healthy young men
61. Physiological hypertrophy does not affect coronary flow reserve in man
62. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men
63. Reduced myocardial flow reserve does not impair exercise capacity in asymptomatic men
64. Alteration in regulation of myocardial blood flow in one-vessel disease determined by positron emission tomography
65. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography
66. Positron emission tomography and the changing paradigm in coronary artery disease
67. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: A study using [150] water dobutamine stress positron emission tomography
68. Indikationen für die klinische anwendung der Positronen-Emissions-Tomographie in der kardiologie: Positionsbericht der PET arbeitsgemeinschaft der deutschen gesellschaft für nuklearmedizin und des arbeitskreises nuklearkardiologie der deutschen gesellschaft für kardiologie
69. Chronic hibernating myocardium: Concepts and controversies
70. Myocyte degeneration and cell death in hibernating human myocardium
71. Non-invasive delineation of the effects of moderate ageing on myocardial perfusion
72. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease
73. Comparison of Rubidium-82 positron emission tomography and Thallium-201 SPECT imaging for detection of coronary artery disease
74. Procedure guideline for myocardial perfusion imaging. Society of Nuclear Medicine
75. Value and limitation of stress thallium-201 single photon emission computed tomography: Comparison with nitrogen-13 ammonia positron emission tomography
76. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting
77. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography
78. The effect of aging on coronary flow reserve in man
79. Delayed recovery of coronary resistive vessel function after coronary angioplasty
80. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction
81. Altered coronary vasodilator reserve and metabolism in myocardium subtended by normal arteries in patients with coronary artery disease
82. Relation between myocardial blood flow and the severity of coronary-artery stenosis
83. Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral-dependent myocardium
84. Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake
85. Recovery of regional left ventricular dysfunction following coronary revascularization: Impact of myocardial viability assessed by nuclear imaging and of vessel patency at follow-up
86. Relationship between regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization
87. Myocardial rubidium-82 tissue kinetics assessed by dynamic positron emission tomography as marker of myocardial cell membrane integrity and viability
88. Satelliten PET in der kardiologischen diagnostik
89. Hibernating Myocardium
90. Koronarreserve nach orthotoper herztransplantation: Quantifizierung mit N-13-ammoniak und der positronenemissionstomographie
91. A new strategy for the assessment of viable myocardium and regional blood flow using O-15 water and dynamic positron emission tomography
92. Nuclear Cardiology (part one)
93. Nuclear Cardiology (part two)
94. Nitrogen-13-ammonia and PET to detect allograft coronary artery disease after heart transplantation: Comparison with coronary angiography